ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 174 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $27,000 | +22.7% | 2,000 | -33.3% | 0.01% | +22.2% |
| Q2 2016 | $22,000 | +15.8% | 3,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $19,000 | 0.0% | 3,000 | 0.0% | 0.01% | +28.6% |
| Q4 2015 | $19,000 | +11.8% | 3,000 | 0.0% | 0.01% | +16.7% |
| Q3 2015 | $17,000 | -32.0% | 3,000 | 0.0% | 0.01% | -33.3% |
| Q2 2015 | $25,000 | 0.0% | 3,000 | 0.0% | 0.01% | +12.5% |
| Q1 2015 | $25,000 | +4.2% | 3,000 | -14.3% | 0.01% | -11.1% |
| Q4 2014 | $24,000 | -20.0% | 3,500 | -36.4% | 0.01% | -25.0% |
| Q3 2014 | $30,000 | +57.9% | 5,500 | +83.3% | 0.01% | +50.0% |
| Q2 2014 | $19,000 | -20.8% | 3,000 | 0.0% | 0.01% | -20.0% |
| Q1 2014 | $24,000 | +20.0% | 3,000 | 0.0% | 0.01% | +11.1% |
| Q4 2013 | $20,000 | -63.6% | 3,000 | 0.0% | 0.01% | -73.5% |
| Q3 2013 | $55,000 | +3.8% | 3,000 | 0.0% | 0.03% | -2.9% |
| Q2 2013 | $53,000 | – | 3,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $80,313,000 | 15.61% |
| Opaleye Management Inc. | 1,310,000 | $8,188,000 | 3.42% |
| Camber Capital Management LP | 5,405,235 | $33,783,000 | 2.18% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 471,516 | $2,947,000 | 1.22% |
| HighVista Strategies LLC | 807,100 | $5,044,000 | 0.94% |
| JS Capital Management LLC | 630,000 | $3,938,000 | 0.94% |
| 1492 Capital Management LLC | 202,500 | $1,266,000 | 0.92% |
| Palo Alto Investors LP | 2,257,217 | $14,108,000 | 0.78% |
| Geduld E E | 185,100 | $1,157,000 | 0.72% |
| Elk Creek Partners, LLC | 1,592,527 | $9,953,000 | 0.71% |